Medistim — M&A Activity 2015

Mar 19, 2015

Annulment of reported mother-daughter merger for Medistim second largest shareholder Salvesen & Thams Invest AS

Annulment of reported mother-daughter merger for Medistim second largest shareholder Salvesen & Thams Invest AS

Salvesen & Thams Invest AS is the second largest

shareholder in Medistim ASA, and is represented on

the Board through Bjørn Wiggen. Bjørn Wiggen is

Chairman of Salvesen & Thams Invest AS, and Chairman

and shareholder of Salvesen & Thams AS.

As announced on the 07.09.2014, shares in Medistim

were planned moved from Salvesen & Thams Invest AS,

up to the parent Salvesen & Thams AS through a

mother-daughter fusion.

Boards of Salvesen & Thams Invest AS and Salvesen &

Thams AS has decided that the merger will not be

implemented. Ownership of the shares in Medistim ASA

are therefore still in Salvesen & Thams Invest AS.

Salvesen & Thams Invest AS is a wholly owned

subsidiary of Salvesen & Thams AS